Literature DB >> 8031434

Extracorporeal circulation in the management of severe tricyclic antidepressant overdose.

J M Williams1, M J Hollingshed, A Vasilakis, M Morales, J E Prescott, G M Graeber.   

Abstract

Extracorporeal circulation is a technique that provides precise control of circulation, oxygenation, temperature, and blood composition in patients suffering from cardiopulmonary failure. The investigators present the case of a near fatal tricyclic antidepressant overdose that failed to respond to standard therapy but was resuscitated using extracorporeal circulation.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8031434     DOI： 10.1016/0735-6757(94)90062-0

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN： 0735-6757            Impact factor:   2.469


  5 in total

Review 1.  Tricyclic antidepressant overdose: a review.

Authors:  G W Kerr; A C McGuffie; S Wilkie
Journal:  Emerg Med J       Date:  2001-07       Impact factor: 2.740

2.  Extracorporeal Membrane Oxygenation (ECMO) for Severe Toxicological Exposures: Review of the Toxicology Investigators Consortium (ToxIC).

Authors:  G S Wang; R Levitan; T J Wiegand; J Lowry; R F Schult; S Yin
Journal:  J Med Toxicol       Date:  2016-03

Review 3.  A review of emergency cardiopulmonary bypass for severe poisoning by cardiotoxic drugs.

Authors:  Nicholas J Johnson; David F Gaieski; Steven R Allen; Jeanmarie Perrone; Francis DeRoos
Journal:  J Med Toxicol       Date:  2013-03

4.  Extracorporeal life support in severe drug intoxication: a retrospective cohort study of seventeen cases.

Authors:  Cédric Daubin; Philippe Lehoux; Calin Ivascau; Marine Tasle; Mehdi Bousta; Olivier Lepage; Charlotte Quentin; Massimo Massetti; Pierre Charbonneau
Journal:  Crit Care       Date:  2009-08-25       Impact factor: 9.097

Review 5.  Clinical review: aggressive management and extracorporeal support for drug-induced cardiotoxicity.

Authors:  Frédéric J Baud; Bruno Megarbane; Nicolas Deye; Pascal Leprince
Journal:  Crit Care       Date:  2007       Impact factor: 9.097
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.